The U.K. cost-effectiveness standard for drugs will increase by 25% in exchange for zero tariffs on the country’s ...
Americans largely trust their doctors but are skeptical of payers, drugmakers and hospital leadership — a divide fueled by ...
A recent Reddit thread on r/HealthInsurance opens with a blunt question: “There’s no more credit reporting on medical debt of any amount since January 2025. Why should I pay any medical bills anymore?
The archaic practice of removing blood from the body to treat a wide range of illnesses lives on today as a standard treatment for certain blood disorders. The modern version of this approach, called ...
Empathy Health Technologies announced Wednesday that it raised $7.6 million to support its Sober Sidekick app, which helps prevent relapse by connecting those struggling with substance use disorder ...
The deadline for extending the Affordable Care Act subsidies is approaching this month. This is happening even as consumers who depend on the ACA Marketplace are faced with the tough decision. Should ...
Digital solutions have greatly expanded access to mental health support, though they’re not always reaching the people who need it the most, such as youth in rural, low-income and marginalized ...
As employers brace for significant healthcare cost increases in 2026, many are seeking out innovative strategies to manage the impact. This comes from the Business Group on Health’s newly released ...
A Pharvaris drug led to speedy relief and symptom resolution from the sudden swelling attacks caused by a rare genetic disorder, preliminary Phase 3 clinical trial results that pave the way for an FDA ...
Light chain amyloidosis is not cancer, but cancer drugs are this rare disease’s standard of care. The patient need for new treatment options has sparked R&D efforts at biotech and big pharmaceutical ...
Regeneron Pharmaceuticals is committing $150 million to begin an alliance on a Tessera Therapeutics gene-editing medicine nearing the clinic as a potential treatment for a rare disease that leads to ...